SRZNW
Surrozen, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
−60.53%Leverage
- Debt / equity
- -0.03x
- Net debt / equity
- 0.44x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 0.29x
Liquidity & coverage
- Current ratio
- 12.14x
- Quick ratio
- 12.14x
- Cash ratio
- 11.32x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $100.4M
Cash & dividend
- FCF / debt
- -5.54x
- Cash flow / debt
- -5.50x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026